Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: TBnet e.V.
Street 1: Armenberg 6
Street 2:
City: Bad Oldesloe
Province: Schleswig-Holstein
Post Code: 23843
Country: Germany
Phone: +****************
Organization Email: cehlers@fz-borstel.de
Web Site: http://www.tb-net.org
Other Online Presence:

Focal Point Contact Information

Salutation: Mrs
First Name: Cordula
Last Name: Ehlers
Title: TBnet Office @ Research Center Borstel
Email: cehlers@fz-borstel.de
Phone: +49 4537 188 7080

Alternate Focal Point Contact Information

Salutation: Prof.
First Name: Graham
Last Name: Bothamley
Title: TBnet Chair
Email: graham.bothamley@homerton.nhs.uk
Phone: +44 20 8510 7814

General Information

Board Constituency: Developed Country NGO
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Organization Description:
TBNET is a network of mostly European, research oriented clinicians, microbiologists, mycobacteriologists and epidemiologists interested in the field of tuberculosis and mycobacterial diseases. It was founded in 2006 by a self-organised group of pulmunologists, epedemiologists and specialists in infectous dieseases in Copenhagen.

The goal of the TBNET is to promote clinically oriented research in the field of tuberculosis in Europe by sharing and developing ideas and research protocols among the members of the network. These goals have been approached by the conduction of observational cohort studies. In the future, a clinical database will be established and cohort studies as well as prospective clinical trials will be performed.
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Research and Development

Other Organization Information

Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 100 +
 
How did you hear about the Stop TB Partnership: Other partners
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
The goal of the TBNET is to promote clinically oriented research in the field of tuberculosis in Europe by sharing and developing ideas and research protocols among the members of the network. These goals have been approached by the conduction of observational cohort studies. In the future, a clinical database will be established and cohort studies as well as prospective clinical trials will be performed.
 

Geographical Reach

Which country is your headquarters located in: Germany
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Argentina
Australia
Austria
Azerbaijan
Belarus
Belgium
Brazil
Bulgaria
Cameroon
Canada
Colombia
Congo
Czech Republic
Denmark
Egypt
Estonia
Ethiopia
Finland
France
Germany
Ghana
Greece
India
Ireland
Israel
Italy
Japan
Latvia
Lithuania
Luxembourg
Malawi
Namibia
Nepal
Netherlands
Norway
Portugal
Republic of Moldova
Republic of Serbia
Romania
Russian Federation
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Tunisia
United Kingdom of Great Britain and Northern Ireland
United Republic of Tanzania
United States of America
Venezuela

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

Drug-Resistant TB:
Within the TB-PANNET TBNET operates a large prospective M/XDR TB multicenter database including patient information from 22 European Centers. For further information: http://www.tbpannet.org/

TB-HIV:
TBNET is currently preparing a consensus statement for the management of HIV and M. tuberculosis coinfection. previous consensus statements (LTBI, the risk of tuberculosis related to TNF antagonists therapy, the risk of tuberculosis related to transplantation can be found on the TBNET website

New Diagnostics:
TBNET is developing and evaluating novel diagnostics methods for the identification of individuals at risk for the development of tuberculosis and for the diagnosis of AFB- smear negative tuberculosis. Ongoing projects and publications related to new diagnostics of tuberculosis can be found on the TBNET website.

New TB Drugs:
TBNET has established clinical trial sites for the evaluation of new anti tuberculosis drugs across Europe and is in contact with industry partners for the evaluation of new drugs.

Fundamental Research:
Fundamental research projects are being performed at specific TBNET colaborating sites e.g. on topics of immunopathogenics tuberculosis.

Research:
Three large diagnostics studies involving several thousand individuals from multiple European centers are currently under way to investigate the predictive value of IGRAs for the development of tuberculosis.
The TBNET-MDR TB database will allow operational research on questions related to risks therapies and outcomes in drug resistance tuberculosis.

Declaration

Declaration of interests:
No conflict of interest is declared

Application date: March 15, 2012
Last updated: March 1, 2016